Latest Georgetown University Medical Center Stories
Glutamate is to the brain like coffee is to our bodies. A cup of Joe in the morning can wake us, but overloading on caffeine causes the stimulant to work against us.
New data about amyloid precursor protein, or APP, a protein implicated in development of Alzheimer's disease, suggests it also may have a positive role -- directly affecting learning and memory during brain development.
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated â€“ a finding that may help fine-tune therapies for depression.
Epileptic seizures are the most dramatic and prominent aspect of the "alcohol withdrawal syndrome" that occurs when a person abruptly stops a long-term or chronic drinking habit.
Researchers say the findings suggest drug therapy targeted against the geneâ€™s protein may be risky.
D.C.'s First Lady Michelle Cross Fenty and Rep. Debbie Wasserman Schultz Celebrate the Capital Breast Care Center WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- Breast cancer. The District of Columbia has the second highest death rate from the disease in the nation.
Groundbreaking center will advance personalized drug development for colon, pancreatic and other gastrointestinal cancers, the most fatal of common cancers. Center established in memory of prominent Washington entrepreneur and philanthropist Otto Ruesch. WASHINGTON, Sept.
Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial â€“ the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease.
Small-bowel transplant patients with an ileostomy -- an opening into their small bowel -- have a very different population of bacteria living in their gut than patients whose ileostomy has been closed.
Kefir, one of the world's oldest "health" drinks, did little to prevent diarrhea in young children being treated with antibiotics, say researchers at Georgetown University Medical Center (GUMC), who tested the drink in a unique and rigorous double-blind clinical trial.
- The parings of haberdine; also, any kind of fragments.